Literature DB >> 2853680

Characterisation of insulin-like growth factor I receptor in skeletal muscles of normal and insulin resistant subjects.

N Livingston1, T Pollare, H Lithell, P Arner.   

Abstract

The insulin-like growth factor I receptor and the activity of its associated tyrosine kinase activity were characterised in wheat germ agglutinin extracts from skeletal muscle biopsies from nine control and ten obese Type 2 (non-insulin-dependent) diabetic subjects, who had marked peripheral in vivo insulin resistance for glucose disposal and hyperinsulinaemia. In parallel studies, the concentration of the insulin receptor and its tyrosine kinase activity were examined in the biopsy extracts and compared to the findings for the insulin-like growth factor I receptor system. Specific binding sites for insulin-like growth factor I were detected. The receptor binding of insulin-like growth factor I was not changed in the obese diabetic subjects as compared to binding activity in the biopsies from the control subjects. The molecular weight of the insulin-like growth factor I receptor alpha subunit was similar in both groups (135 kDa). The insulin-like growth factor I stimulated tyrosine kinase activity was also similar for the two groups. In contrast, insulin binding activity was 30% less in the receptor extracts from the in vivo insulin resistant group when compared to the control group. Moreover, insulin-stimulated tyrosine kinase activity was reduced in the former group by 40% when the value was corrected for insulin binding. Thus, specific insulin-like growth factor I receptors are present in human skeletal muscle. These receptors are normal in insulin resistant obese Type 2 diabetic subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853680     DOI: 10.1007/bf00265369

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin.

Authors:  C Poggi; Y Le Marchand-Brustel; J Zapf; E R Froesch; P Freychet
Journal:  Endocrinology       Date:  1979-09       Impact factor: 4.736

2.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Arner; T Pollare; H Lithell; J N Livingston
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

3.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

Authors:  E A McGuire; J H Helderman; J D Tobin; R Andres; M Berman
Journal:  J Appl Physiol       Date:  1976-10       Impact factor: 3.531

Review 4.  Actions of insulin-like growth factors.

Authors:  E R Froesch; C Schmid; J Schwander; J Zapf
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

Review 5.  Assessment of insulin sensitivity in vivo.

Authors:  R N Bergman; D T Finegood; M Ader
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

6.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.

Authors:  J F Caro; M K Sinha; S M Raju; O Ittoop; W J Pories; E G Flickinger; D Meelheim; G L Dohm
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

7.  Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM.

Authors:  M K Sinha; W J Pories; E G Flickinger; D Meelheim; J F Caro
Journal:  Diabetes       Date:  1987-05       Impact factor: 9.461

8.  Glucose turnover values in the dog obtained with various species of labeled glucose.

Authors:  N Altszuler; A Barkai; C Bjerknes; B Gottlieb; R Steele
Journal:  Am J Physiol       Date:  1975-12

9.  Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age.

Authors:  K Tan; R C Baxter
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

10.  Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver.

Authors:  J F Caro; J Poulos; O Ittoop; W J Pories; E G Flickinger; M K Sinha
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

View more
  4 in total

1.  Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II.

Authors:  S M Rosenthal; A Brunetti; E J Brown; P W Mamula; I D Goldfine
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

2.  Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.

Authors:  R Laager; R Ninnis; U Keller
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

3.  Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.

Authors:  P D Zenobi; S E Jaeggi-Groisman; W F Riesen; M E Røder; E R Froesch
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

4.  Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects.

Authors:  P Arner; T Pollare; H Lithell
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.